This Amedeo Smart survey is supported by Pfizer Oncology.
AmedeoBreast Cancer |
|
Free Subscription
Int J Oncol |
- May 2026
- WANG W, Zhao P, Wang T, Wu W, et al
Diverse roles of SERPINE1 in regulating cellular proliferation and invasion.
Int J Oncol. 2026;68:58.
>> Share
- LI K, Wei L, Huang Y, Wu Y, et al
[Corrigendum] Leptin promotes breast cancer cell migration and invasion via IL?18 expression and secretion.
Int J Oncol. 2026;68:51.
>> Share
April 2026 - CHEN ZM, Huang P, Yang DY, Lin S, et al
Advances in the study of the breast carcinoma exosomal microRNAs: From basic mechanisms to clinical applications (Review).
Int J Oncol. 2026;68:38.
>> Share
- LIU J, Du H, Shi Y
Role and underlying mechanisms of miR?200 family in breast cancer (Review).
Int J Oncol. 2026;68:43.
>> Share
March 2026 - ZHANG N, Wang T, Bai B, Zhang X, et al
PTPN18 functions as a tumor suppressor in breast cancer by negatively regulating cyclin E.
Int J Oncol. 2026;68:30.
>> Share
- VIEDMA-RODRIGUEZ R, Baiza-Gutman LA, Garcia-Carranca A, Moreno-Fierros L, et al
[Retracted] Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF?7 breast cancer cells.
Int J Oncol. 2026;68:29.
>> Share
January 2026 - MALLA RR, Raghu H, Rao JS
[Expression of Concern] Regulation of NADPH oxidase (Nox2) by lipid rafts in breast carcinoma cells.
Int J Oncol. 2026;68:1.
>> Share
- LI K, Wei L, Huang Y, Wu Y, et al
[Expression of Concern] Leptin promotes breast cancer cell migration and invasion via IL?18 expression and secretion.
Int J Oncol. 2026;68:3.
>> Share
- LUO J, Yang Y, Cheng L, Cheng F, et al
Discovery of the late autophagy inhibitor FZU?0045?053 and its anti?breast cancer and immunomodulatory effects.
Int J Oncol. 2026;68:10.
>> Share
- LI F, Gao Z
Obesity, chronic breast inflammation and carcinogenesis: Molecular pathways and clinical implications (Review).
Int J Oncol. 2026;68:12.
>> Share
December 2025 - HUA K, Jin J, Zhao J, Song J, et al
[Expression of Concern] miR?135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
Int J Oncol. 2025;67:96.
>> Share
- GELSOMINO L, Del Console P, Murfuni MS, Gaspari M, et al
Adipocyte?derived extracellular vesicles sustain mitochondrial metabolism in breast cancer cells: New insights into the cross?talk between cancer cells and the tumor microenvironment.
Int J Oncol. 2025;67:100.
>> Share
- JIN ML, Park SY, Kim YH, Park G, et al
[Expression of Concern] Halofuginone induces the apoptosis of breast cancer cells and inhibits migration via downregulation of matrix metalloproteinase?9.
Int J Oncol. 2025;67:106.
>> Share
November 2025 - ZOU X, Li S, Huang S, Niu R, et al
Harnessing TP73?targeted nintedanib: A novel strategy to halt triple?negative breast cancer via p53?PPARalpha/PI3K?Akt pathway suppression.
Int J Oncol. 2025;67:88.
>> Share
- HUANG X, Luo W, Liu W, Liu X, et al
Progerin regulates actin cytoskeletal remodeling and inhibits EMT and metastasis in triple?negative breast cancer cells.
Int J Oncol. 2025;67:92.
>> Share
August 2025 - KAUSAR MA, Alshammari KF, Alenazi F, Anwar S, et al
RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review).
Int J Oncol. 2025;67:65.
>> Share
- CHUNG SS, Giehl N, Wu Y, Vadgama JV, et al
[Corrigendum] STAT3 activation in HER2?overexpressing breast cancer promotes epithelial?mesenchymal transition and cancer stem cell traits.
Int J Oncol. 2025;67:69.
>> Share
July 2025 - PARK AY, Kim JH, Lee S, Kim HS, et al
Impact of PD?L1 upregulation on immune checkpoint inhibitor efficacy in triple?negative breast cancer using a 4T1 murine model.
Int J Oncol. 2025;67:54.
>> Share
June 2025 - ZHANG X, Zhao X, Shao S, Zuo X, et al
[Retracted] Notch1 induces epithelial?mesenchymal transition and the cancer stem cell phenotype in breast cancer cells and STAT3 plays a key role.
Int J Oncol. 2025;66:46.
>> Share
- KIM ES
Molecular targets and therapies associated with poor prognosis of triple?negative breast cancer (Review).
Int J Oncol. 2025;66:52.
>> Share
May 2025 - SUN MX, Zhu HC, Yu Y, Yao Y, et al
Role of the Wnt signaling pathway in the complex microenvironment of breast cancer and prospects for therapeutic potential (Review).
Int J Oncol. 2025;66:36.
>> Share
- GIL EY, Jo UH, Jeong H, Whang YM, et al
[Retracted] Promoter methylation of RASSF1A modulates the effect of the microtubule?targeting agent docetaxel in breast cancer.
Int J Oncol. 2025;66:39.
>> Share
January 2025 - LEE WX, Yeo BS, Mahmud R, Tan GC, et al
MicroRNAs and their role in breast cancer metabolism (Review).
Int J Oncol. 2025;66:7.
>> Share
October 2024 - SOLEK J, Braun M, Sadej R, Romanska HM, et al
FGFR?related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review).
Int J Oncol. 2024;65:94.
>> Share
September 2024 - YANG Y, Gao F, Ren L, Ren N, et al
Functions and mechanisms of RNA m(6)A regulators in breast cancer (Review).
Int J Oncol. 2024;65:86.
>> Share
- FU Z, Song P, Li D, Yi C, et al
[Corrigendum] Cancer?associated fibroblasts from invasive breast cancer have an attenuated capacity to secrete collagens.
Int J Oncol. 2024;65:87.
>> Share
May 2024 - AI L, Yi N, Qiu C, Huang W, et al
Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review).
Int J Oncol. 2024;64:46.
>> Share
April 2024 - MBUGUA RW, Takano A, Tsevegjav B, Yokose T, et al
Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer.
Int J Oncol. 2024;64:43.
>> Share
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016
